Abstract:Chronic kidney disease (CKD) is common in patients with heart failure (HF) and is associated with high morbidity and mortality. There has been remarkable progress in the treatment of HF over recent years with the establishment of guideline-directed medical therapies including: (1) Beta-blockers, (2) renal angiotensin aldosterone system (RAAS) inhibition (i.e., angiotensin-converting enzyme inhibitor [ACEi], aldosterone receptor blocker [ARB] or angiotensin receptor-neprilysin inhibitor [ARNI]); (3) mineralocorticoid receptor antagonists (MRA), and (4) sodium-glucose cotransporter-2 inhibitors (SGLT2i). However, there are challenges to the implementation of these medications in patients with concomitant CKD due to increased vulnerability to common side-effects (including worsening renal function, hyperkalaemia, hypotension), and most of the pivotal trials which provide evidence of the efficacy of these medications excluded patients with severe CKD. Patients with CKD and HF often have regular healthcare encounters with multiple professionals and can receive conflicting guidance regarding their medication. Thus, despite being at higher risk of adverse cardiovascular events, patients who have both HF and CKD are more likely to be under-optimised on evidence-based therapies. This review is an updated summary of the evidence available for the management of HF (including reduced, mildly reduced and preserved left ventricular ejection fraction) in patients with various stages of CKD. The review covers the evidence for recommended medications, devices such as implantable cardioverter-defibrillator (ICD), cardiac resynchronization therapy (CRT), intravenous (IV) iron, and discusses how frailty affects the management of these patients. It also considers emerging evidence for the prevention of HF in the cohort of patients with CKD. It synthesises the available evidence regarding when to temporarily stop, continue or rechallenge medications in this cohort. Chronic HF in context of CKD remains a challenging scenario for clinicians to manage, which is usually complicated by frailty, multimorbidity and polypharmacy. Treatment should be tailored to a patients individual needs and management in specialised cardio-renal clinics with a multi-disciplinary team approach has been recommended. This review offers a concise summary on this expansive topic.

New Insights on Cardiac Arrhythmias in Patients With Kidney Disease

Frequency of arrhythmia symptoms and acceptability of implantable cardiac monitors in Hemodialysis patients

Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients With Overt Chronic Kidney Disease: JACC State-of-the-Art Review

The conundrum of the complex relationship between acute kidney injury and cardiac arrhythmias

Cardiac Devices and Kidney Disease

Chronic Kidney Disease Induces Proarrhythmic Remodeling

Arrhythmias and Sudden Cardiac Death in End Stage Renal Disease: Epidemiology, Risk Factors, and Management

Atrial Fibrillation in Chronic Kidney Disease: An Overview

Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.

Do Implantable Cardioverter-Defibrillators Prevent Sudden Cardiac Death in End-Stage Renal Disease Patients on Dialysis?

Cardiac metabolic remodelling in chronic kidney disease

Heart failure with reduced ejection fraction and chronic kidney disease: a focus on therapies and interventions

Cardiac Stress in Chronic Kidney Disease: Unraveling the Myocardial Paradox

Diagnosis of cardiovascular disease in patients with chronic kidney disease

An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease

Cardiac Arrhythmias and Their Management: An In-Depth Review of Current Practices and Emerging Therapies

Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

Insights into the Association of Chronic Kidney Disease (CKD) and Cardiovascular Risk Among Diabetic vs Non-Diabetic Patients

Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

Unraveling the Complexities of T wave Alternans and QT Prolongation in Advanced Chronic Kidney Disease: A Case Report and Literature Review

Navigating the Crossroads: Understanding the Link Between Chronic Kidney Disease and Cardiovascular Health